Although OPG binds RANKL and TRAIL with the same affinity in vitro [133], the addition of excess RANKL is able to reverse the effect of OPG on TRAIL-mediated apoptosis in human breast cancer cells [125]. Here, TNFRSF11B is linked to breast cancer.